STAT
DECEMBER 30, 2024
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to estimate the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October. The CBO should be commended for conducting this comprehensive analysis.
Drug Topics
DECEMBER 30, 2024
Check out this list of our top 5 most read diabetes stories from the year 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 30, 2024
Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.
The Checkup by Singlecare
DECEMBER 30, 2024
Sold under brand names such as Amvaz, Katerzia, Norliqva, and Norvasc , amlodipine is a medication that is FDA approved for the treatment of hypertension (high blood pressure), chronic stable angina (chest pain and pressure), vasospastic angina (coronary artery spasm), and coronary artery disease. It belongs to a class of medications called calcium channel blockers, which is further broken down into two classes: dihydropyridine calcium channel blockers and nondihydropyridine calcium channel bloc
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
DECEMBER 30, 2024
Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts. Axsome, which is based in New York, announced Monday that its drug AXS-05 met the primary endpoint of one trial testing the therapy for agitation caused by Alzheimer’s, but failed to show statistical significance in another.
The Checkup by Singlecare
DECEMBER 30, 2024
Gabapentin is a prescription anticonvulsant drug (aka an anti-seizure medication) and pain medication. It can help treat seizures and relieve anxiety. According to a 2024 study in Animals, gabapentin is also safe and well-tolerated for dogs with behavior disorders. As far as pain management, dogs who have degenerative joint diseases or nerve pain may need gabapentin to treat chronic pain or neuropathic pain.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
DECEMBER 30, 2024
Veterinarians do not use the skeletal muscle relaxant tizanidine in dogs. There are no veterinary studies on the effects or safety of tizanidine in companion animals and no published dosages. If a dog is given or accidentally eats tizanidine, thats a potential veterinary emergency requiring inducing vomiting or monitoring the dog in a veterinary clinic.
Pharmacy Times
DECEMBER 30, 2024
The disparity highlights opportunities for pharmacists to get involved and address health disparities.
The Checkup by Singlecare
DECEMBER 30, 2024
Most people have heard the brand name Valium. Diazepam is the generic version. Veterinarians commonly use it as a sedative, anxiety treatment , seizure medication , and muscle relaxant in cats and dogs. Its often used on an as-needed basis, but veterinarians are cautious about giving cats diazepam on a daily basis. Some cats can experience life-threatening liver injury when taking daily oral diazepam.
pharmaphorum
DECEMBER 30, 2024
Learn how digital biomarkers are revolutionising respiratory care by providing personalised, real-time data for better monitoring and management of respiratory diseases.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
DECEMBER 30, 2024
It is strongly recommended that people with Type 1 or Type 2 diabetes , or gestational diabetes , frequently monitor their blood glucose (sugar) levels at home. Some use a blood glucose meter which requires a finger stick, while others prefer using a continuous glucose monitor (CGM). A popular personal CGM system is the FreeStyle Libre 3 Plus sensor.
European Pharmaceutical Review
DECEMBER 30, 2024
The use of advanced therapies using cells or genes to achieve significant leaps in medical treatment was perceived as a niche sector just a decade ago, but it has now started to garner a greater level of understanding and recognition in the pharmaceutical industry. Numerous groundbreaking advances have shown these therapies hold potential to revolutionise how we treat, and potentially cure, many conditions, including for patients with underlying genetic or cellular causes of disease that have
The Checkup by Singlecare
DECEMBER 30, 2024
Hailing from the same drug category, telmisartan and losartan are generic drugs that help to reduce blood pressure by the same mechanism. They are angiotensin II receptor blockers (ARBs), and by inhibiting the action of angiotensin II, ARBs lower blood pressure by reducing blood vessel constriction and renal retention of salt and water. These effects on our kidneys and cardiovascular system have led to uses besides simply treating hypertension.
pharmaphorum
DECEMBER 30, 2024
BMS beats MSD to the US subcutaneous PD-1 inhibitor market after Opdivo Qvantiq is cleared across nearly all the indications of the IV form
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 30, 2024
Plaintiff argues that "blacklisting certain individuals with opioid prescriptions was unlawful.
pharmaphorum
DECEMBER 30, 2024
Daiichi Sankyo has claimed its first approval, in Japan, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan
Pharmacy Times
DECEMBER 30, 2024
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia.
Pharmaceutical Technology
DECEMBER 30, 2024
MTX-COVAB is under clinical development by Memo Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 30, 2024
Panelists discuss understanding the comparative advantages, decision-making factors, infrastructure requirements, and partnership models for administering bispecific antibodies in community vs academic settings, with particular focus on patient care logistics and referral pathways.
Compounding Pharmacy of America
DECEMBER 30, 2024
Discover how compounded medications provide effective pain relief for dental dry socket. Learn about personalized solutions to speed healing and ease discomfort. The post Dental Dry Socket Compounded Medication for Pain Relief appeared first on Compounding Pharmacy of America.
Pharmacy Times
DECEMBER 30, 2024
Panelists discuss how key recommendations for optimizing bispecific therapy care focus on establishing robust communication protocols between academic and community centers while ensuring community centers develop comprehensive infrastructure including staff training, emergency protocols, and care coordination pathways.
Compounding Pharmacy of America
DECEMBER 30, 2024
Learn effective strategies for managing allergies, including compounded medications tailored to your symptoms. Find relief with personalized treatments for allergy care The post Allergy Management and Relief appeared first on Compounding Pharmacy of America.
Pharmaceutical Commerce
DECEMBER 30, 2024
A dive into the top articles in this sector making waves this year.
Compounding Pharmacy of America
DECEMBER 30, 2024
Learn how pediatric compounding pharmacies offer customized medications for children, addressing challenges like taste, dosage, and allergies, while improving treatment outcomes. The post Are you looking for a better way to give your child medicine? appeared first on Compounding Pharmacy of America.
Pharmaceutical Technology
DECEMBER 30, 2024
The US FDA has granted approval for Bristol Myers Squibbs (BMS) Opdivo Qvantig for subcutaneous use to treat various solid tumours.
PharmExec
DECEMBER 30, 2024
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), how new radiological techniques are revolutionizing the diagnosis of conditions like endometriosis and the impact it will have on patients.
Pharmaceutical Technology
DECEMBER 30, 2024
Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma (ESCC).
PharmExec
DECEMBER 30, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
DECEMBER 30, 2024
ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Pancreatic Ductal Adenocarcinoma.
The Checkup by Singlecare
DECEMBER 30, 2024
Soma, the brand name for the generic medication Carisoprodol, is a muscle relaxant given to those with pain related to musculoskeletal conditions. The prescription drug is part of the skeletal muscle relaxant class of medications. Due to the risk of substance abuse on this medicine, some may wonder if Soma is considered a controlled substance. We went to the medical experts to learn everything you want to know about Soma and its potential for drug abuse.
Pharmaceutical Technology
DECEMBER 30, 2024
ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Metastatic Colorectal Cancer.
STAT
DECEMBER 30, 2024
It’s easy to forget that we live in an age of medical wonders. Cancer tumors can be slowed or shrunk in ways previous generations couldn’t imagine, with everything from pills to genetically engineered white blood cells. Surgeons can transplant a face, or replace a heart valve without cracking a chest. These are outcomes that would not have been possible 20 years ago.
Pharmaceutical Technology
DECEMBER 30, 2024
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase I for Breast Cancer.
Expert insights. Personalized for you.
129 
Let's personalize your content